↓ Skip to main content

American Association for Cancer Research

Article Metrics

Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?

Overview of attention for article published in Cancer Epidemiology, Biomarkers & Prevention, April 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
3 tweeters

Readers on

mendeley
4 Mendeley
Title
Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?
Published in
Cancer Epidemiology, Biomarkers & Prevention, April 2021
DOI 10.1158/1055-9965.epi-19-1580
Pubmed ID
Authors

Eman Biltaji, Brandon Walker, Trang H. Au, Zachary Rivers, Jennifer Ose, Christopher I. Li, Diana I. Brixner, David D. Stenehjem, Cornelia M. Ulrich

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 4 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 4 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 50%
Researcher 1 25%
Student > Postgraduate 1 25%
Readers by discipline Count As %
Medicine and Dentistry 2 50%
Economics, Econometrics and Finance 1 25%
Biochemistry, Genetics and Molecular Biology 1 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 June 2021.
All research outputs
#11,461,642
of 18,240,594 outputs
Outputs from Cancer Epidemiology, Biomarkers & Prevention
#2,580
of 4,013 outputs
Outputs of similar age
#183,093
of 328,221 outputs
Outputs of similar age from Cancer Epidemiology, Biomarkers & Prevention
#37
of 60 outputs
Altmetric has tracked 18,240,594 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,013 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.4. This one is in the 32nd percentile – i.e., 32% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 328,221 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 60 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.